Average Co-Inventor Count = 3.45
ph-index = 4
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Cephalon, Inc. (13 from 247 patents)
2. Ignyta, Inc. (3 from 25 patents)
16 patents:
1. 10632119 - Fused bicyclic 2,4-diaminopyrimidine derivative as a dual ALK and FAK inhibitor
2. 10150772 - Crystalline forms of PARP inhibitors
3. 10111872 - Fused bicyclic 2,4-diaminopyrimidine derivative as a dual ALK and FAK inhibitor
4. 9987281 - Solid state forms of a quinazoline derivative and its use as a BRAF inhibitor
5. 9718810 - Solid state forms of a quinazoline derivative and its use as a BRAF inhibitor
6. 9623026 - Fused bicyclic 2,4-diaminopyrimidine derivative as a dual ALK and FAK inhibitor
7. 9353097 - Solid state forms of a quinazoline derivative and its use as a BRAF inhibitor
8. 9339502 - Fused bicyclic 2,4-diaminopyrimidine derivative as a dual ALK and FAK inhibitor
9. 9132128 - Fused bicyclic 2,4-diaminopyrimidine derivative as a dual ALK and FAK inhibitor
10. 8633314 - Forms of a multicyclic compound
11. 8513272 - Forms of a fused pyrrolocarbazole compound
12. 7749540 - Compositions comprising modafinil compounds
13. 7704975 - Modafinil compound and cyclodextrin mixtures
14. 7141555 - Modafinil compound and cyclodextrin mixtures
15. 6919378 - Pharmaceutical solutions of modafinil compounds